Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Muscle Invasive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00847015
What this trial is testing

Gemcitabine, Cisplatin, and Sunitinib (GC-S) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer

Who this might be right for
Bladder CancerUrinary Bladder
Memorial Sloan Kettering Cancer Center 18
Testing effectiveness (Phase 2)Study completedNCT00583349
What this trial is testing

Intravesicular Abraxane for Treatment-Refractory Bladder Cancer

Who this might be right for
Bladder Cancer
Columbia University 46
Early research (Phase 1)Study completedNCT03191578
What this trial is testing

Immunological Response to Intravesical BCG Therapy of Superficial Bladder Cancer by Prior Administration of RUTI®

Who this might be right for
High-Risk Non-Muscle-Invasive Bladder Cancer
Archivel Farma S.L. 44
Not applicableUnknownNCT03597087
What this trial is testing

The Difference of Two Year Recurrence Rate According to Anesthetic Method During Transurethral Resection of Bladder Mass in Patients With Non-muscle Invasive Bladder Cancer: Prospective, Randomized, Clinical Phase II Study

Who this might be right for
Bladder Cancer
Seoul National University Hospital 289
Not applicableStudy completedNCT02710682
What this trial is testing

Tendon Fenestration Versus Surgery for the Treatment of Chronic Lateral Epicondylosis

Who this might be right for
Epicondylitis of the ElbowTennis Elbow
Centre hospitalier de l'Université de Montréal (CHUM) 64
Not applicableUnknownNCT05084586
What this trial is testing

Comparison of the Efficacy and Safety of Continuous and Single-Dose Intravesical Epirubicin Instillation

Who this might be right for
Bladder CancerEpirubicin Adverse ReactionSuperficial Bladder Cancer+1 more
Ankara Training and Research Hospital 100
Testing effectiveness (Phase 2)Looking for participantsNCT05203913
What this trial is testing

Cisplatin, Nab-paclitaxel, Nivolumab With Radiotherapy After Resection of Non-Metastatic Muscle Invasive Bladder Cancer

Who this might be right for
Muscle-Invasive Bladder Carcinoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 32
Not applicableLooking for participantsNCT06735287
What this trial is testing

A Bladder-Sparing Treatment Strategies of Large-Volume Non-Muscle-Invasive Bladder Cancer

Who this might be right for
Bladder CancerNMIBC
The First Affiliated Hospital with Nanjing Medical University 60
Large-scale testing (Phase 3)WithdrawnNCT03298958
What this trial is testing

Secondary Prevention Trial of Rapamycin in Patients With Resected Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
The University of Texas Health Science Center at San Antonio
Not applicableNot Yet RecruitingNCT07744958
What this trial is testing

RESTORE-BLADDER (REgistry on STrategies for Organ pREservation in Muscle-invasive BLADDER Cancer)

Who this might be right for
Muscle Invasive Bladder Cancer (MIBC)
Heinrich-Heine University, Duesseldorf 100
Not applicableStudy completedNCT02969109
What this trial is testing

Validation of a Urine-based Assay With Genomic Markers for Predicting Recurrence for Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer
Genomic Health®, Inc. 417
Large-scale testing (Phase 3)UnknownNCT04490993
What this trial is testing

Safety and Efficacy of APL-1202 in Combination With Epirubicin Hydrochloride Versus Epirubicin Hydrochloride Alone in Intermediate and High-risk Chemo-refractory Non-muscle Invasive Bladder Cancer (NMIBC) Patients

Who this might be right for
Non-muscle Invasive Bladder Cancer
Jiangsu Yahong Meditech Co., Ltd aka Asieris 359
Early research (Phase 1)Active Not RecruitingNCT05843448
What this trial is testing

IDO and PD-L1 Peptide Based Immune-Modulatory Therapeutic (IO102-IO103) in Combination With Pembrolizumab for BCG-Unresponsive or Intolerant, Non-Muscle Invasive Bladder Cancer

Who this might be right for
High Risk Non-Muscle Invasive Bladder Urothelial CarcinomaStage 0a Bladder Cancer AJCC v8Stage 0is Bladder Cancer AJCC v8+1 more
University of California, Davis 6
Testing effectiveness (Phase 2)Looking for participantsNCT06511648
What this trial is testing

Erdafitinib Monotherapy or in Combination With Cetrelimab in Muscle-invasive Bladder Cancer Patients With Fibroblast Growth Factor Receptor (FGFR ) Gene Alterations

Who this might be right for
Muscle-invasive Bladder Cancer
Spanish Oncology Genito-Urinary Group 90
Early research (Phase 1)Study completedNCT06350838
What this trial is testing

Clinical Study to Investigate the Safety and Tolerance of Therapeutic BCG in Postoperative Adjuvant Therapy in Subjects With Moderate to High-risk Non-muscular Invasive Bladder Cancer (NMIBC)

Who this might be right for
Non-muscular Invasive Bladder Cancer
Chengdu CoenBiotech Co., Ltd 10
Not applicableStudy completedNCT04521426
What this trial is testing

Ventilator-associated Injury (VAI) in Chronic Home Mechanical Ventilation

Who this might be right for
Respiratory FailureLong-term Non-invasive Ventilation
University Medical Center Groningen 15
Testing effectiveness (Phase 2)Looking for participantsNCT07122414
What this trial is testing

Intravesical FL115 Alone or in Combination With BCG in Non-Muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer (NMIBC)
Suzhou Forlong Biotechnology Co., Ltd 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07808216
What this trial is testing

Toripalimab Combined With Intravesical Gemcitabine as Adjuvant Therapy for High-Risk Non-Muscle-Invasive Bladder Cancer After TURBT

Who this might be right for
Non Muscle Invasive Bladder Cancer
Tianjin First Central Hospital 54
Large-scale testing (Phase 3)Not Yet RecruitingNCT07198451
What this trial is testing

Efficacy of Gemcitabine Submucosal Injection for Preventing Recurrence in Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer: A Randomized Trial

Who this might be right for
Non Muscle Invasive Bladder Cancer
Shanghai University of Traditional Chinese Medicine 320
Not applicableUnknownNCT05478928
What this trial is testing

Invasive Techniques in Trigger Points

Who this might be right for
Trigger Point Pain, Myofascial
Maimonides University 60
Next Page